Developing new technology to identify types of cancer resistant to chemotherapy and radiotherapy

Specialists from the Kuban Medical University have developed technology that allows identifying molecular genetic types of cancer that are insensitive to radiation and chemotherapy and require immediate surgical intervention.

According to what was reported by the press service of the Russian Ministry of Education and Science program “Priority 2030”, within the framework of which the research is being conducted, this will help transport patients to the hospital and perform surgery in a timely manner, and will also help reduce cases of ineffective treatment.

The press service noted that scientists at the Kuban State Medical University have discovered characteristic signs on cancer cells, based on which the effectiveness of classical treatments for breast cancer and squamous cell carcinoma of the oropharynx can be determined. In the next stage, scientists plan to develop software that will help doctors choose the appropriate treatment.

The software will work like a calculator, where it is enough to enter several specifications obtained during the biopsy to find out whether it is necessary to immediately perform surgery or whether chemotherapy or radiotherapy should be started.

Assistant Professor in the Department of Oncology at the Faculty of Raising the Professional Competence of Specialists, Anastasia Stukan, explained: “The choice in favor of chemotherapy or radiotherapy in the first stage of treatment of malignant diseases is often based only on the size of the tumor without taking into account its molecular characteristics, which leads to low efficiency.” "High toxicity, delayed surgery, and increased number of relapses."